Recurrent PNET with MGMT methylation responds to temozolomide.
Oh
Jiwon
J
Divison of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Bilbao
Juan M
JM
Tsao
May N
MN
Fazl
Mahmood
M
Guiot
Marie-Christine
MC
Del Maestro
Rolando F
RF
Perry
James R
JR
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008745:Methylation; D018242:Neuroectodermal Tumors, Primitive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide